Skip to main content
Skip to navigation

Featured Profile: Amy Vogelsmeier

Amy Vogelsmeier

Dr. Amy Vogelsmeier’s research on patient safety has garnered accolades.

When patients transition between care settings (such as hospitals and nursing homes), healthcare professionals perform a safety practice called medication reconciliation—a complex clinical process designed to reduce the likelihood of adverse drug effects. Vogelsmeier is among the first to explore nurses’ roles in the process. Studies show that many adverse events in skilled nursing facilities, such as falls, bleeding, delirium and hypoglycemic episodes, are tied to medication use, and many of these events are considered preventable. Vogelsmeier has found that registered nurses (RNs) are more likely than licensed practical nurses (LPNs) to discover high-risk medication discrepancies.

“Currently, RNs are not functioning in nursing homes to the full scope of their practice,” says Vogelsmeier. RNs and LPNs often have interchangeable responsibilities, but Vogelsmeier’s work demonstrates that this can lead to more medication errors. Assigning medication reconciliation to RNs could prevent adverse events among nursing home residents.

Vogelsmeier is recognized as a patient-safety expert by the National Council of State Boards of Nursing as well as the Agency for Healthcare Research and Quality, and she regularly consults for the Center for Patient Safety. In 2015, she was inducted as a Fellow into the prestigious American Academy of Nursing.

Dr. Amy Vogelsmeier is an associate professor of nursing and John A. Hartford Foundation Claire M. Fagin Fellow in the University of Missouri’s Sinclair School of Nursing.

Download a PDF of this story.

Related Initiative(s):
One Health/One Medicine